Starting in the new year, the region’s largest health insurer will no longer cover popular diabetes drugs for the purposes of ...

In recent developments, health officials in Europe have launched an investigation into the popular weight loss drug Ozempic, amid alarming reports of a possible connection to a serious eye ...